Prosecution Insights
Last updated: April 19, 2026

Examiner: SVEIVEN, MICHAEL CAMERON

Tech Center 1600 • Art Units: 1678

This examiner grants 31% of resolved cases

Performance Statistics

31.3%
Allow Rate
-28.7% vs TC avg
50
Total Applications
+43.6%
Interview Lift
1408
Avg Prosecution Days
Based on 16 resolved cases, 2023–2026

Rejection Statute Breakdown

9.9%
§101 Eligibility
20.1%
§102 Novelty
34.3%
§103 Obviousness
24.7%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
17427213 SYSTEMS FOR EVOLVED ADENO-ASSOCIATED VIRUSES (AAVS) FOR TARGETED DELIVERY Final Rejection The Broad Institute, Inc.
17914149 DEVICES FOR DETECTING ANTIBODIES TO CORONAVIRUS ANTIGENS AND METHODS FOR USING THEM Final Rejection The Regents of the University of California
18052537 METHODS FOR IDENTIFICATION OF ANTIGEN-BINDING MOLECULES Non-Final OA 10x Genomics, Inc.
17708786 INTEGRATION OF A PROTEIN COLOCALIZATION DEVICE (PCD) ONTO A MICROFLUIDIC DEVICE Final Rejection Nautilus Subsidiary, Inc.
18045037 LARGE MOLECULE UNSPECIFIC CLEARANCE ASSAY Final Rejection Hoffmann-La Roche Inc.
17661428 PEPTIDE BASED PROBES FOR THE DETECTION OF SARS-COV-2 Non-Final OA Massachusetts Institute of Technology
17684639 METHODS AND COMPOSITIONS FOR DETECTING PROTEIN TARGETS Final Rejection THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM
17771053 Zero Power Visible Colorimetric Pathogen Sensors Non-Final OA University of Utah Research Foundation
17777011 SILICA SHELL ENCAPSULATED POLYAROMATIC-CORE MICROPARTICLES Non-Final OA Arizona Board of Regents on Behalf of the University of Arizona
16975351 EZETIMIBE METABOLITE AS A NON-INVASIVE BIOMARKER FOR NON-ALCOHOLIC STEATOHEPATITIS (NASH) Non-Final OA ARIZONA BOARD OF REGENTS ON BEHALF OF THE UNIVERSITY OF ARIZONA
17995849 CALIBRATION AND QUALITY CONTROL REAGENTS FOR USE WITH IMMUNOASSAYS FOR ANTIBODIES AND METHODS OF PRODUCTION AND USE THEREOF Non-Final OA Siemens Healthcare Diagnostics Inc.
17915981 METHOD FOR IMMUNOASSAY OF AMYLOID BETA IN BLOOD, AND KIT FOR SAME Non-Final OA FUJIREBIO INC.
17685906 BIOASSAY METHOD Final Rejection Amneal Pharmaceuticals LLC
18327118 CONCENTRATION ESTIMATION KIT AND CONCENTRATION ESTIMATION METHOD Non-Final OA Tianma Japan, Ltd.
17928039 A METHOD FOR MULTIPLE STAINING AND SLIDE PREPARATION FOR A CYTOPATHOLOGICAL SAMPLE Non-Final OA Daoxiang WANG
17711222 LATERAL FLOW DEVICES AND METHODS Non-Final OA SALUS DISCOVERY, LLC
17560909 METHOD FOR SMALL-RNA BIOMARKER IDENTIFICATION AND FUNCTIONAL EVALUATION OF CIRCULATING EXTRACELLULAR VESICLES COMPRISING EXOSOMES Final Rejection HACKENSACK MERIDIAN HEALTH CENTER FOR DISCOVERY AND INNOVATION
17480322 Sexed Sperm Bulk Separation Systems Final Rejection Cytolutions, LLC
17433322 CELLS AND METHODS FOR EVALUATING THE ACTIVITY OF ORGANIC ANION TRANSPORTING POLYPEPTIDE 2A1 (OATP2A1) Final Rejection ABSORPTION SYSTEMS LLC
16897576 DETECTION OF HORMONES IN HAIR SAMPLES AND OTHER BIOLOGICAL SAMPLES Final Rejection MedAnswers, Inc.

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month